The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations
Abstract
Beginning in 1992, the Agency for Health Care Policy and Research and the National Institute of Mental Health funded the Schizophrenia Patient Outcomes Research Team (PORT) to develop and disseminate recommendations for the treatment of schizophrenia based on existing scientific evidence. These Treatment Recommendations, presented here in final form for the first time, are based on exhaustive reviews of the treatment outcomes literature (previously published in Schizophrenia Bulletin, Vol. 21, No. 4, 1995) and focus on those treatments for which there is substantial evidence of efficacy. The recommendations address antipsychotic agents, adjunctive pharmacotherapies, electroconvulsive therapy, psychological interventions, family interventions, vocational rehabilitation, and assertive community treatment/intensive case management. Support for each recommendation is referenced to the previous PORT literature reviews, and the recommendations are rated according to the level of supporting evidence. The PORT Treatment Recommendations provide a basis for moving toward "evidence-based" practice for schizophrenia and identify both the strengths and limitations in our current knowledge base.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is, therefore, likely that discontinuation studies employing linear dose reductions,74,83,84,86,87 as recommended in some older guidelines,94 will be more likely to induce withdrawal reactions (including, potentially, withdrawal psychosis) because reductions in D2 antagonism become increasingly large, causing greater likelihood of dopaminergic rebound.”
From A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse (2021) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021
Family Interventions for Schizophrenia
Dixon, L. B., & Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.631 · Cited by 394
Self-citationPsychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 271
Vocational Rehabilitation in Shizophrenia
Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.645 · Cited by 239
Self-citationAssertive Community Treatment and Case Management for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.657 · Cited by 226
Conventional Antipsychotic Medications for Schizophrenia
Dixon, L. B., Lehman, A. F., & Levine, J. A. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.567 · Cited by 182
Self-citationClozapine: Efficacy and Safety
Buchanan, R. W. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.579 · Cited by 161
Psychological Interventions for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.621 · Cited by 134
Risperidone: Efficacy and Safety
Umbricht, D., & Kane, J. M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.593 · Cited by 73
Research works printed but not linked: 4
- Kane, J.M. Schizophrenia. New England Journal of Medicine, 334:34-41, 1996.
- Kane, J.M., and Marder, S.R. Psychopharmacologic treat- ment of schizophrenia. Schizophrenia Bulletin, 19(2): 287-302, 1993.
- Lehman, A.F. Vocational rehabilitation in schizophrenia. Schizophrenia Bulletin, 21(4):645-656, 1995.
- Zito, J.M. Psychotherapeutic Drug Manual. 3rd ed. New York, NY: John Wiley & Sons, 1994.
Cited by
Sorted by citations
Items 101–200 of 900
Service Use Among Patients With Schizophrenia in Psychoeducational Multiple-Family Group Treatment
Dyck, D. G., HENDRYX, M. S., Short, R., Voss, W. D., & McFarlane, W. R. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.6.749 · Cited by 126
Management of the Negative Symptoms of Schizophrenia
M??ller, H.-J. (2003) · CNS Drugs · doi:10.2165/00023210-200317110-00003 · Cited by 125
The Mount Sinai Conference on the Pharmacotherapy of Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Davis, J. M., Kane, J. M., Lieberman, J. A., & Schooler, N. R. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006926 · Cited by 125
Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study
Gråwe, R. W., Falloon, I. R. H., Widen, J. H., & Skogvoll, E. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00799.x · Cited by 124
Mancini, A. D., Moser, L. L., Whitley, R., McHugo, G. J., Bond, G. R., Finnerty, M. T., & Burns, B. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.2.189 · Cited by 122
Quality of life of clients with schizophrenia
Chan, S. W., & Yu, I. W. (2003) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2003.02863.x · Cited by 122
Sharif, F., Shaygan, M., & Mani, A. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-48 · Cited by 121
Barriers to Evidence-Based Practice Implementation: Results of a Qualitative Study
Rapp, C. A., Etzel-Wise, D., Marty, D., Coffman, M., Carlson, L. S., Asher, D., Callaghan, J., & Holter, M. C. (2009) · Community Mental Health Journal · doi:10.1007/s10597-009-9238-z · Cited by 121
OPEN DIALOGUE IN PSYCHOSIS II: A COMPARISON OF GOOD AND POOR OUTCOME CASES
Seikkula, B. A. J., Alakare, B., & Aaltonen, J. (2001) · Journal of Constructivist Psychology · doi:10.1080/10720530126129 · Cited by 119
The fundamentals of workforce competency: implications for behavioral health
Hoge, M. A., Tondora, J., & Marrelli, A. F. (2005) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-005-3263-1 · Cited by 119
Intervention Research in Psychosis: Issues Related to the Assessment of Quality of Life
Awad, A. G., & Voruganti, L. N. P. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033477 · Cited by 118
Annotation: Childhood‐onset schizophrenia: clinical and treatment issues
Asarnow, J. R., Tompson, M. C., & McGrath, E. P. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00213.x · Cited by 118
Disease Management in Latinos With Schizophrenia: A Family-Assisted, Skills Training Approach
Kopelowicz, A. J., Zárate, R. C., Smith, V. G., Mintz, J., & Liberman, R. P. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006999 · Cited by 117
Rotondi, A. J., Haas, G. L., ANDERSON, C. M., Newhill, C. E., Spring, M. B., Ganguli, R., Gardner, W., & Rosenstock, J. B. (2005) · Rehabilitation Psychology · doi:10.1037/0090-5550.50.4.325 · Cited by 116
Barton, R. (1999) · Psychiatric Services · doi:10.1176/ps.50.4.525 · Cited by 115
Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative
Dixon, L. B., Goldman, H. H., Srihari, V. H., & Kane, J. M. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084934 · Cited by 112
“In the first set of PORT recommendations (Lehman & Steinwachs 1998a), 18 of the 30 recommendations focused on the use of antipsychotic medications for acute and maintenance treatment.”
BackgroundA comparison of electronic records to paper records in mental health centers
Tsai, J., & Bond, G. R. (2007) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzm064 · Cited by 110
Scheyett, A., & Kim, M. (2004) · Journal of Teaching in Social Work · doi:10.1300/j067v24n01_03 · Cited by 110
Do new prescription drugs pay for themselves?
Duggan, M. (2004) · Journal of Health Economics · doi:10.1016/j.jhealeco.2004.08.001 · Cited by 108
de Haan, L., Linszen, D. H., Lenior, M. E., de Win, E. D., & Gorsira, R. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007009 · Cited by 108
Caregiving and Caregiver Interventions in Aging and Mental Illness
Biegel, D. E., & Schulz, R. (1999) · Family Relations · Cited by 107
Bond, G. R., Drake, R. E., Becker, D. R., & Mueser, K. T. (1999) · Journal of Disability Policy Studies · doi:10.1177/104420739901000104 · Cited by 107
Medication Adherence Among Psychotic Patients Before Admission to Inpatient Treatment
Rittmannsberger, H., Pachinger, T., Keppelmüller, P., & Wancata, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.2.174 · Cited by 105
LESLIE, D. L., & Rosenheck, R. A. (2001) · Medical Care · doi:10.1097/00005650-200109000-00003 · Cited by 105
Priorities of Consumers, Providers, and Family Members in the Treatment of Schizophrenia
Fischer, E. P., Shumway, M., & Owen, R. R. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.6.724 · Cited by 103
Ascher‐Svanum, H., Nyhuis, A. W., Faries, D., Kinon, B. J., Baker, R. W., & Shekhar, A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm134 · Cited by 103
High concordance between self-reported medication and official prescription database information
Haukka, J. K., Suvisaari, J., Tuulio‐Henriksson, A., & Lönnqvist, J. K. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0349-6 · Cited by 102
Mellman, T. A., Miller, A. L., Weissman, E. M., Crismon, M. L., Essock, S. M., & Marder, S. R. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.5.619 · Cited by 102
Are randomised controlled trials the only gold that glitters?
Slade, M., & Priebe, S. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.4.286 · Cited by 101
Adding Consumer-Providers to Intensive Case Management: Does It Improve Outcome?
Rivera, J. J., Sullivan, A. M. T., & Valenti, S. S. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.802 · Cited by 100
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Uchida, H., Suzuki, T., Takeuchi, H., Arenovich, T., & Mamo, D. C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp149 · Cited by 101
Evidence-based treatment of schizophrenia
Drake, R. E., Mueser, K. T., Torrey, W. C., Miller, A. L., Lehman, A. F., Bond, G. R., Goldman, H. H., & LEFF, H. S. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0021-7 · Cited by 99
Self-citationHaro, J. M., Edgell, E. T., Novick, D., Alonso, J., Kennedy, L., Jones, P. B., Ratcliffe, M., Breier, A. F., & SOHO advisory board (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00450.x · Cited by 99
Extract of Ginkgo biloba Treatment for Tardive Dyskinesia in Schizophrenia
Zhang, W.-F., Tan, Y.-L., Zhang, X., Chan, R. C. K., Wu, H.-R., & Zhou, D.-F. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05125yel · Cited by 98
A Theory of Social Integration as Quality of Life
Ware, N. C., Hopper, K. J., Tugenberg, T., Dickey, B., & Fisher, D. R. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.1.27 · Cited by 96
Chien, W. T., & Chan, S. W. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.11.1276 · Cited by 96
Cullberg, J., Mattsson, M. S., Levander, S., Holmqvist, R., Tomsmark, L., Elingfors, C., & Wieselgren, I. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00788.x · Cited by 96
Hazel, N. A., McDonell, M. G., Short, R., Berry, C. M., Voss, W. D., Rodgers, M. L., & Dyck, D. G. (2003) · Psychiatric Services · doi:10.1176/appi.ps.55.1.35 · Cited by 95
Effect of a Mental Health “Carve-Out” Program on the Continuity of Antipsychotic Therapy
Ray, W. A., Daugherty, J. R., & Meador, K. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa020584 · Cited by 94
Forbes, M. K., Kotov, R., Ruggero, C. J., Watson, D., Zimmerman, M. A., & Krueger, R. F. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.04.006 · Cited by 98
Converting Day Treatment Centers to Supported Employment Programs in Rhode Island
Becker, D. R., Bond, G. R., McCarthy, D., Thompson, D., Xie, H., McHugo, G. J., & Drake, R. E. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.3.351 · Cited by 94
Multidisciplinary team working: Collaboration and conflict
Jones, A. (2006) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2006.00400.x · Cited by 92
Wang, P. S., West, J. C., Tanielian, T., & Pincus, H. A. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033465 · Cited by 92
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia
Wong, J., Hyde, T. M., Cassano, H., Deep‐Soboslay, A., Kleinman, J. E., & Weickert, C. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.037 · Cited by 95
Rosenbaum, B., Harder, S. K., Knudsen, P. B., Køster, A., Lindhardt, A., Lajer, M., Valbak, K., & Winther, G. (2012) · Psychiatry · doi:10.1521/psyc.2012.75.4.331 · Cited by 91
Cellular and Humoral Immune System in Schizophrenia: A Conceptual Re-Evaluation
Müller, N., Riedel, M. J., Ackenheil, M., & Schwarz, M. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150588 · Cited by 91
Magnabosco, J. L. (2006) · Implementation Science · doi:10.1186/1748-5908-1-13 · Cited by 90
Sibling perspectives on severe mental illness: Reflections on self and family.
Lukens, E. P., Thorning, H., & Lohrer, S. P. (2004) · American Journal of Orthopsychiatry · doi:10.1037/0002-9432.74.4.489 · Cited by 95
Clinical epidemiologic first‐episode psychosis: 1‐year outcome and predictors
Simonsen, E. H., Friis, S., Haahr, U., Johannessen, J. O., Larsen, T. K., Melle, I. S., Opjordsmoen, S., Rund, B. R., Vaglum, P., & McGlashan, T. H. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00942.x · Cited by 86
Computer-Assisted Self-Assessment in Persons With Severe Mental Illness
Chinman, M., Young, A. S., Schell, T. L., Hassell, J., & Mintz, J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1008 · Cited by 86
Kelly, D. L., Conley, R. R., & Carpenter, W. T. (2005) · Drugs · doi:10.2165/00003495-200565080-00006 · Cited by 86
Racial Disparity in the Use of Atypical Antipsychotic Medications Among Veterans
Copeland, L. A., Zeber, J. E., Valenstein, M. M., & Blow, F. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1817 · Cited by 85
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J. A., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S. S., Fang, B., Peterson, E., Aquino, P. R., et al. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.2.194 · Cited by 85
Cost-effectiveness of current and optimal treatment for schizophrenia
Andrews, G., Sanderson, K., Corry, J., Issakidis, C., & Lapsley, H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.5.427 · Cited by 83
Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes
Vegter, S., Boersma, C., Rozenbaum, M. H., Wilffert, B., Navis, G. J., & Postma, M. J. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826070-00005 · Cited by 83
Evidence‐based practice in mental health: practical weaknesses meet political strengths
Tanenbaum, S. J. (2003) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.2003.00409.x · Cited by 83
Lewandowski, K. E., Cohen, B. M., Keshavan, M. S., & Öngür, D. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.09.004 · Cited by 81
Moser, L. L., DeLuca, N. L., Bond, G. R., & Rollins, A. L. (2004) · CNS Spectrums · doi:10.1017/s1092852900009780 · Cited by 81
Prediction of Outcome from the Dartmouth Assertive Community Treatment Fidelity Scale
Bond, G. R., & Salyers, M. P. (2004) · CNS Spectrums · doi:10.1017/s1092852900009792 · Cited by 80
Providing services to families of persons with schizophrenia: present and future
Dixon, L. B. (1999) · The Journal of Mental Health Policy and Economics · doi:10.1002/(sici)1099-176x(199903)2:1 · Cited by 80
Reite, M. L., Teale, P. D., Rojas, D. C., Reite, E., Asherin, R. M., & Hernandez, O. O. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00701.x · Cited by 79
Evidence-based practices: setting the context and responding to concerns
Essock, S. M., Goldman, H. H., Tosh, L. V., Anthony, W. A., Appell, C. R., Bond, G. R., Dixon, L. B., Dunakin, L. K., Ganju, V. K., Gorman, P., et al. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00069-8 · Cited by 79
The Incarceration of Individuals with Severe Mental Disorders
Munetz, M. R., Grande, T. P., & Chambers, M. R. (2001) · Community Mental Health Journal · doi:10.1023/a:1017508826264 · Cited by 79
Comparative Safety of Antipsychotic Medications in Nursing Home Residents
Huybrechts, K. F., Schneeweiß, S., Gerhard, T., Olfson, M., Avorn, J., Levin, R., Lucas, J. A., & Crystal, S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03853.x · Cited by 80
Kong, L., Bachmann, S., Thomann, P. A., Essig, M., & Schröder, J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.09.015 · Cited by 78
Racial Disparity in the Pharmacological Management of Schizophrenia
Kreyenbuhl, J. A., ZITO, J. M., Buchanan, R. W., Soeken, K. L., & Lehman, A. F. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006996 · Cited by 78
Self-citationBest Practices in Coordinated CarePreprint
Chen, A., Brown, R., Archibald, N. D., Aliotta, S. L., & Fox, P. D. (2000) · RePEc: Research Papers in Economics · Cited by 78
Therapeutic Limit Setting in an Assertive Community Treatment Program
Neale, M. S., & Rosenheck, R. A. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.4.499 · Cited by 77
A Call for a Mental Health Services Research Agenda for Youth with Serious Emotional Disturbance
Burns, B. J. (1999) · Mental Health Services Research · doi:10.1023/a:1021927100830 · Cited by 77
Cohen, A. N., Glynn, S. M., Murray-Swank, A. B., Barrio, C., Fischer, E. P., McCutcheon, S. J., PERLICK, D. A., Rotondi, A. J., Sayers, S. L., Sherman, M. D., et al. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.1.40 · Cited by 76
Clinical Handbook of Eating Disorders: An Integrated Approach
Gearhart, L. (2007) · Psychiatric Services · doi:10.1176/appi.ps.58.2.273 · Cited by 76
How Many Assertive Community Treatment Teams Do We Need?
Cuddeback, G. S., MORRISSEY, J. P., & Meyer-Kalos, P. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.12.1803 · Cited by 75
Young, A. S., Forquer, S. L., Tran, A. N., Starzynski, M., & Shatkin, J. P. (2000) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02291743 · Cited by 75
Evidence-based psychotherapeutic interventions in the community care of schizophrenia
Thornicroft, G., & Susser, E. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.1.2 · Cited by 75
LESLIE, D. L., & Rosenheck, R. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1534 · Cited by 75
Deficit Schizophrenia: Association With Serum Antibodies to Cytomegalovirus
Dickerson, F., Kirkpatrick, B., Boronow, J. J., Stallings, C. R., Origoni, A. E., & Yolken, R. H. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi054 · Cited by 74
Viviano, J. D., Buchanan, R. W., Calarco, N., Gold, J. M., Foussias, G., Bhagwat, N., Stefanik, L., Hawco, C. S., DeRosse, P., Árgyelán, M., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.03.013 · Cited by 73
Guideline-Concordant Antipsychotic Use and Mortality in Schizophrenia
Cullen, B., McGinty, E. E., Zhang, Y., dosReis, S., Steinwachs, D. M., Güallar, E., & Daumit, G. L. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs097 · Cited by 73
Self-citationChien, W. T., & Chan, S. W. (2013) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2013.01.004 · Cited by 72
Trends in the Rate and Type of Antipsychotic Medications Prescribed to Persons With Schizophrenia
Rothbard, A. B., Kuno, E., & Foley, K. T. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007025 · Cited by 72
Kaas, M. J., Lee, S., & Peitzman, C. (2003) · Issues in Mental Health Nursing · doi:10.1080/mhn.24.8.741.756 · Cited by 72
The promise of early intervention
Addington, J. (2007) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2007.00043.x · Cited by 72
Early intervention in psychosis: a new evidence based paradigm
McGorry, P. D., & Killackey, E. J. (2002) · Epidemiology and Psychiatric Sciences · doi:10.1017/s1121189x00005807 · Cited by 71
Schizophrenia guidelines across the world: A selective review and comparison
Gäebel, W., Riesbeck, M., & Wobrock, T. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.606801 · Cited by 73
Intermediate phenotypes in schizophrenia: a selective review
Preston, G. A., & Weinberger, D. R. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.2/gpreston · Cited by 70
Do needs, symptoms or disability of outpatients with schizophrenia influence family burden?
Ochoa, S., Vilaplana, M., Haro, J. M., Villalta‐Gil, V., Martínez, F., Negredo, M., Casacuberta, P., Paniego, E., Usall, J., Dolz, M., et al. (2008) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0337-x · Cited by 69
Quality Of Care In Mental Health: The Case Of Schizophrenia
Lehman, A. F. (1999) · Health Affairs · doi:10.1377/hlthaff.18.5.52 · Cited by 69
Self-citationFamily intervention in early psychosis
McNab, C., & LINSZEN, D. H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576287.018 · Cited by 68
Clozapine Augmentation: Safety and Efficacy
Chong, S. A., & Remington, G. J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033463 · Cited by 68
Edwards, N. C., Locklear, J. C., Rupnow, M. F. T., & Diamond, R. J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523001-00007 · Cited by 67
Pharmacological Management of First-Episode Schizophrenia and Related Nonaffective Psychoses
Bradford, D. W., Perkins, D. O., & Lieberman, J. A. (2003) · Drugs · doi:10.2165/00003495-200363210-00001 · Cited by 67
Salyers, M. P., Bond, G. R., Teague, G. B., Cox, J. F., Smith, M. E., Hicks, M. L., & Koop, J. I. (2003) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287319 · Cited by 67
Oosthuizen, P. P., Emsley, R. A., Turner, H. J., & Keyter, N. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004262 · Cited by 67
Consumer and Family Psychoeducation: Assessing the Evidence
Lyman, D. R., Braude, L., George, P., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300266 · Cited by 66
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
Zhang, M., & Mao, Y. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62266 · Cited by 65
Evaluation of Antipsychotic and Concomitant Medication Use Patterns in Patients With Schizophrenia
Williams, C. L., Johnstone, B. M., Kesterson, J. G., Javor, K. A., & Schmetzer, A. D. (1999) · Medical Care · doi:10.1097/00005650-199904001-00011 · Cited by 65
Community mental health teams: evidence or belief?
Thornicroft, G., Becker, T. M., Holloway, F., Johnson, S., Leese, M., McCrone, P., SZMUKLER, G. I., Taylor, R., & Wykes, T. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.6.508 · Cited by 65
Olivares, J. M., Rodríguez-Martínez, A., Burón, J. A., Alonso‐Escolano, D., & Rodríguez-Morales, A. (2008) · Applied Health Economics and Health Policy · doi:10.2165/00148365-200806010-00004 · Cited by 64
Borges, G. L. G., Medina‐Mora, M. E., Wang, P. S., Lara, C., Berglund, P. A., & Walters, E. E. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1371 · Cited by 64
Quality of life in Chinese elderly people with depression
Chan, S. W., Chiu, H. F. K., Chien, W. T., Thompson, D. R., & LAM, L. C. W. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1461 · Cited by 64
Metadata
- Authors
- Lehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project
- Affiliations
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Corresponding author
- Lehman, A. F.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-01-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2121113553
- Cited by
- 910
- References
- 14
- Citations by year
- 2025: 6 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 8 · 2019: 12 · 2018: 23 · 2017: 12 · 2016: 17 · 2015: 14 · 2014: 16 · 2013: 22 · 2012: 41
- FWCI
- 38.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia
- MeSH terms
- Combined Modality Therapy, Health Policy, Humans, Research Support as Topic, Schizophrenia, United States, United States Agency for Healthcare Research and Quality, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review